Drug Channels Archive for September, 2024


Click a link below to view the mailing archive as if it had been sent to you.

2024-09-30 07:47Drug Channels - Informa Connect's Copay, Reimbursement and Access Congress
2024-09-27 07:47Drug Channels - The Pivotal Role of Technology in Delivering Effective Patient Services
2024-09-25 07:47NEW: The Drug Channels 2025 Video Webinar Series
2024-09-24 07:40Drug Channels News Roundup, September 2024: Inside JNJ's Gross-to-Net Bubble, Optum Rx's Private Label Biosimilars, Where Biosimilars Boom, Accumulators vs. Patients, and Steve Collis Retires
2024-09-23 15:02Drug Channels - Best Practices for Successfully Transitioning a Patient Services Hub
2024-09-23 07:47Drug Channels - Informa Connnect's Pharma/Biotech GTN Summit
2024-09-20 07:47Drug Channels - Best Practices for Successfully Transitioning a Patient Services Hub
2024-09-17 07:47Drug Channels - Available for Preorder: The 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
2024-09-16 07:47Drug Channels - Informa Connect's Patient Support Services Congress
2024-09-13 07:50Drug Channels - GoodRx: Evolving & Expanding Integrated Platform Partnerships to Drive Access, Affordability & Outcomes
2024-09-11 07:47Drug Channels - White Bagging Update 2024: Providers' Pushback Preserves Buy-and-Bill
2024-09-10 07:47Drug Channels Leadership Forum: Full Agenda Now Available (Spoiler: It's Awesome!)
2024-09-06 07:47Drug Channels - Three Areas to Watch: The Inflation Reduction Act and Prescription Pricing
2024-09-04 07:43Drug Channels - Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble?
2024-09-03 11:01Drug Channels - The Healthcare Innovation Company's Value-Based Care Summit

 

<< Archive IndexSubscribe >>